Peptonic Medical

Focus: Peptonic Medical is a Swedish biotech company focused on OTC and prescription treatments for women's health conditions, particularly vaginal atrophy and bacterial vaginosis. The company operates as a specialized player in an underserved women's health segment.

Women's Health

Profile data last refreshed Yesterday · AI intelligence enriched 1w ago

Open Jobs

About Peptonic Medical

AI assessmentNot Hiring

No open roles listed right now. Follow Peptonic Medical to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

9 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Vagivital

Vaginal Atrophy

N/A

Clinical Trials (1)

NCT03998722Evaluation of VagiVital® for Treatment of Vaginal Atrophy

N/A

Help build intelligence for Peptonic Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Focused portfolio in women's health—a historically underinvested therapeutic area with growing market demand and less competitive saturation than oncology or cardiology
Multiple Phase 2 programs (4 oxytocin and vaginal formulation assets) provide near-term clinical catalysts and milestone-driven career progression opportunities
Stockholm headquarters offers access to Nordic biotech ecosystem while maintaining focus on an underserved patient population with clear clinical need

Watch Out For

No active job openings (0 posted roles) signals limited near-term hiring and potential operational constraints or early-stage focus
Pre-revenue status with unknown funding and employee count raises questions about long-term financial stability and runway
Early-stage pipeline (no Phase 3 programs, no marketed products) means limited near-term revenue visibility and extended path to regulatory success

Generated by Claude from Peptonic Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

D005 Vaginal Mousse

Bacterial Vaginosis &#X7C; Vaginal &#X7C; Microbiology

N/A

Clinical Trials (1)

NCT04489290Efficacy and Safety of D005 Vaginal Mousse on Bacterial Vaginosis

N/A

D005 vaginal mousse

Bacterial Vaginoses

N/A

Clinical Trials (1)

NCT06104098A User Study With Vernivia® for Bacterial Vaginosis.

N/A